Go to main content

FCDO ODA allocations for 2021/22 were announced on 21 April 2021. Changes to individual programmes are underway. The information on this website may not reflect the latest allocated budgets for this year. This information will be updated in due course.

  1. Home
  2. Developing countries, unspecified
  3. COVID-19 vaccine funding for the COVAX Advance Market Commitment using IFFIm.

UK - Foreign, Commonwealth and Development Office (FCDO)

COVID-19 vaccine funding for the COVAX Advance Market Commitment using IFFIm.

UK aid from the British people

Project Data Last Updated: 04/06/2021

IATI Identifier: GB-GOV-1-301271


The UK is supporting early access to COVID-19 vaccines for the world’s poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK’s international objectives of bringing the pandemic under control and supporting global economic recovery.

Status - Implementation More information about project status
Project Spend More information about project funding
Participating Organisation(s) More information about implementing organisation(s)

Sectors groups as a percentage of country budgets according to the Development Assistance Committee's classifications.


A comparison across six financial years of forecast spend and the total amount of money spent on the project to date.

This site uses cookies

We use Google Analytics to measure how you use the website so we can improve it based on user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the internal pages you visit, how long you spend on each page and what you click on while you're visiting the site. Read more